Billion Dollar Healthcare Giant P3 Health Partners Inc. Focused on Helping

HENDERSON, Nev. - Feb. 22, 2023 - PRLog -- $PIII Adjusted EBITDA Anticipated to be Positive in 2024.

Health Management Network of Over 2,500 Affiliated Primary Care Providers Across the USA.

Currently Serving Over 100,000 Patients in 15 Counties Across Five States.

Revenue Guidance for 2022 Given as a 61% to 69% Increase Over 2021.

Membership Growth Projected at Roughly a 35% Increase Over Prior Year.

For 2023 Revenue is Expected in a Range of $1.20 to $1.25 Billion.

Highly Experienced New CFO Appointed.

P3 Health Partners, Inc.  is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers. Founded and led by physicians, PIII has an expansive network of more than 2,500 affiliated primary care providers across the country.

PIII local teams of health care professionals manage the care of more than 100,000 patients in 15 counties across five states. PIII supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, the PIII care team creates an enhanced patient experience by navigating, coordinating, and integrating the patient's care within the healthcare system.

PIII is a leader in population health management because the company embraces a care model and patient support team that is effective in:

Empowering patients to improve their own health by providing the necessary tools and resources to prevent, manage and navigate illness.

Freeing doctors from time-consuming administrative processes and paper-pushing so they can focus on our patients.

Fostering patients that are informed, conscientious, manage their own long-term health and are less likely to utilize high-cost services.

Fighting disease before it starts with a healthier patient that, if they face a health issue, is better suited to achieve their own best outcome.

DISCLAIMER: This article is purely for informational purposes and is not a recommendation in any way for buying or selling stocks

SOURCE: CorporateAds.com